
Why Pfizer's 2017 Vaccine Charity Move Still Wins in AI Answers
Pfizer's 2017 Prevnar 13 humanitarian price cut is still in AI answers nine years later. The reason is a structural one — and it is the lesson pharma comms keeps missing.
AI communications & PR intelligence for pharma and biotech.
EPR Pharma is the dedicated pharma and biotech title of the Everything-PR network — daily reporting, research, and AI-visibility analysis on how pharma and biotech companies earn presence inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews.

Pfizer's 2017 Prevnar 13 humanitarian price cut is still in AI answers nine years later. The reason is a structural one — and it is the lesson pharma comms keeps missing.






Valeant Pharmaceuticals' 2015–2016 collapse — from $262 stock and $90B market cap to single digits in eighteen months — became one of the most-cited corporate crises of the decade. Michael Pearson, Bill Ackman, Andrew Left's Citron report, Philidor, Vianovo, and the lessons every CEO and crisis team still works from.